The American College of Medial Genetics and Genomics (ACMG) announced today that press registration is now open for the 2026 ...
Canal Row Advisors, a multidisciplinary team of former FDA and industry leaders with deep regulatory, clinical, compliance, and policy expertise, announced today that it has launched a new ...
Silicone’s composition gives it a synthetic polymer structure with a silicon-oxygen backbone, making it more resistant to ...
Doneil Henry has been building his soccer portfolio since retiring as a player in 2023. And the 32-year-old former Canadian ...
Q4 2025 preliminary net product revenues from global sales of IMCIVREE ® (setmelanotide) of approximately $57 million for the fourth quarter of 2025, an 11% increase over Q3 2025 -- -- FY 2025 ...
A year from now, Gov. Jared Polis will wrap up eight years as the state’s chief executive officer, take off the governor’s ...
Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic ...
Phase 3 SELVA study evaluating QTORIN rapamycin 3.9% anhydrous gel (QTORIN rapamycin) for microcystic lymphatic malformations (microcystic LMs) remains on track, with topline results anticipated in Ma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback